Population-based cardiovascular risk factors in the elderly in Turkey: a cross-sectional survey
Author:
Ozkara Adem1, Turgut Faruk2, Kanbay Mehmet2, Selcoki Yusuf3, Akcay Ali2
Affiliation:
1. 1Department of Family Medicine, Fatih University, School of Medicine, Ankara, Turkey 2. 2Department of Nephrology, Fatih University, School of Medicine, Ankara, Turkey 3. 3Department of Cardiology, Fatih University, School of Medicine, Ankara, Turkey
Abstract
AbstractHypertension, diabetes, hyperlipidaemia, obesity and smoking are known to be the most important modifiable risk factors for cardiovascular disease (CVD). Because the elderly population has been increasing globally, CVD may become a more important public health problem in the future. This report examines the prevalence of cardiovascular risk factors in the elderly in Ankara, Turkey. This was a cross-sectional survey and included a total of 2720 individuals living in the Ankara district. Trained research staff administered a standard questionnaire in the participants’ homes and worksites. The questionnaire collected information on clinical and demographic characteristics and a self-reported medical history, including past history of hypertension, diabetes, hyperlipidemia, coronary artery disease, coronary artery by-pass graft operation, and cerebrovascular accident. The mean age of the study participants was 69.5 ± 7.2 years. The study identified 1298 women (78.1%) and 753 men (71.2%) with hypertension, and the overall prevalence of hypertension was 75.4%. A total of 739 (27.2%) people had diabetes mellitus, and, of these people, 603 (81.6%) were hypertensive. A total of 1361 people had hyperlipidemia, and 1103 of these patients were also hypertensive. The overall prevalence of obesity was 27.2%. A total of 553 (20.3%) people were smokers. Our findings indicate that cardiovascular risk factors are very common in the elderly. To maximize risk reduction, physicians must take aggressive measures to decrease cardiovascular risk factors.
Publisher
Walter de Gruyter GmbH
Reference20 articles.
1. World Health Organization: The World Health Report ‘Reducing risks, Promoting Healthy Life, Geneva’, World Health Organization, 2002 2. Chobanian A.C., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L. Jr., et al., National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure., The JNC 7 Report, JAMA., 2003, 289, 2560–2572 3. He J., Whelton P.K., Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease, J. Hypertens Suppl., 1999, 17, 7–13 4. Van den Hoogen P.C.W., Feskens E.J.M., Nagelkerke N.J.D., Menotti A., Nissinen A., Kromhout D., for the Seven Countries Study Research Group. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world, N. Engl. J. Med. 2000, 342, 1–8 5. He J., Whelton P.K., Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials, Am. Heart J., 1999, 138, 211–219
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|